Tokyo, Oct. 3 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059264) titled 'Data collection study on a fundus diagnosis support program using a portable fundus camera' on Oct. 2.

Study Type: Observational

Primary Sponsor: Institute - Hirohsima University

Condition: Condition - glaucoma Classification by malignancy - Others Genomic information - NO

Objective: Narrative objectives1 - This study utilizes a handheld fundus camera for healthcare professionals to observe the fundus, collect images, and gather clinical information. This enables observation of fundus morphology differences associated with glaucoma presence and collects training and validation data (images and clinical information) for future development of an AI program supporting glaucoma diagnosis. Basic objectives2 - Others

Eligibility: Age-lower limit - 18 years-old <= Age-upper limit - Not applicable Gender - Male and Female Key inclusion criteria - 1. Age 18 or older at the time of consent acquisition (gender not specified) 2. Patients for whom written informed consent regarding participation in this study can be obtained 3. Patients deemed by a physician to be suitable candidates for examination of retinal diseases 3. Patients for whom a physician deems examination for retinal disease desirable Key exclusion criteria - 1. Patients determined by the principal investigator or co-investigator to be clearly at undue disadvantage by participating in the study 2. Patients determined by the principal investigator or co-investigator to clearly impede the conduct or evaluation of this clinical research by participating in the study Target Size - 200

Recruitment Status: Recruitment status - Open public recruiting Date of protocol fixation - 2025 Year 08 Month 04 Day Date of IRB - 2025 Year 09 Month 17 Day Anticipated trial start date - 2025 Year 10 Month 02 Day Last follow-up date - 2027 Year 07 Month 31 Day

To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000067197

Disclaimer: Curated by HT Syndication.